NCT07833306: Efficacy and Safety of ATTO-1310 in the Treatment of Participants With Chronic Pruritus of Unknown Origin
- State
- Not started
- Phase
- Phase 2
- People
- 300 planned
- Started
- 21 Dec 2026
- Primary completion
- 30 Aug 2028
- Arms
- ATTO-1310 Dose A, ATTO-1310 Dose B, ATTO-1310 Dose C, ATTO-1310 Dose D, ATTO-1310 Dose E, ATTO-1310 dose F
- Results
- None posted
- 22 Sep 2026: Trial registered